Neurodegeneration: The Biological Pathways Driving the Future of Therapeutic Development
joint with Neuro-Immune Interactions in the Central Nervous System
Scientific Organizers: Dimitri Krainc and Alfred W. Sandrock Jr.
Date: June 05 - 09, 2022
|InPerson Location: Keystone Resort, Keystone, CO, USA|
|Meeting is available as a Livestream, click register button below for more details|
|Meeting is available to view On Demand, click register button below for more details|
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Neurodegenerative diseases remain one of the main concerns for aging populations across the world. Elucidating the molecular mechanisms underlying these diseases thus remains a priority for developing effective therapeutics to combat them. Recent genetic studies linked to these diseases have pointed to functional defects in several key cellular organelles and pathways that appear to drive neurodegeneration, including endolysosomal, mitochondrial and synaptic dysfunctions. However, there is still much to be learned regarding the precise roles of these pathways in disease progression, their contribution to neuronal vulnerability, and how to effectively target these pathways in patients. Important mechanistic themes in neurodegenerative disease include the genetics of neuro-immune interactions, the involvement of synaptic molecular events, the role of endolysosomal, autophagic and mitochondrial dysfunction, the potential contribution of dynamic inter-organelle contact sites in neurons, and translational considerations including the use of biomarkers and gene therapy. The goal of this conference is to bring together fundamental basic scientists who are experts in these areas of cell biology, together with clinicians and medical researchers, and scientists investigating therapeutic strategies for neurodegeneration. By combining these different fields of expertise, this conference will stimulate cross-fertilization, in-depth interactions and insightful discussions on disease pathogenesis and strategies for advancing drug development for neurodegenerative disorders. Finally, this conference is being paired with a conference on Neuro-Immune Interactions in the Central Nervous System. This combination will be beneficial in that it will emphasize the crossover between neurodegeneration and neuroimmunology. As neuroimmunology is a recently reinvigorated field, this meeting will provide a critical opportunity to foster cross-disciplinary thinking.
Global Health Award Deadline: May 16 2022 details
Scholarship Deadline: February 22 2022 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
All those submitting an abstract should plan to attend in-person to ensure extensive interaction opportunities. At this time we recognize that a small percentage of submitters may be unable to travel due to border crossing restrictions and/or institutional travel bans. If these restrictions are still in place during the meeting, permissions for remote presentations will be given for the exceptional circumstances listed above.
NOTE: In the event that your abstract isn't selected for a short talk and you're not able to travel the abstract fee is nonrefundable. All paid abstracts will be included in the meeting app and meeting materials available online.